Items where Author or Contributor is "Sallam, H"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Number of items: 4.

Bibliographic data only

Bettayeb, K; Sallam, H; Ferandin, Y; Popowycz, F; Fournet, G; Hassan, M; Echalier, A; Bernard, P; Endicott, J; Joseph, B; +1 more... Meijer, L; (2008) N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine. Molecular cancer therapeutics, 7 (9). pp. 2713-24. ISSN 1535-7163 DOI: https://doi.org/10.1158/1535-7163.MCT-08-0080 Full text not available from this repository.

Iurisci, I; Filipski, E; Sallam, H; Harper, F; Guettier, C; Maire, I; Hassan, M; Iacobelli, S; Lévi, F; (2009) Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiology international, 26 (6). pp. 1169-88. ISSN 0742-0528 DOI: https://doi.org/10.3109/07420520903209942 Full text not available from this repository.

Sallam, H; Jimenez, P; Song, H; Vita, M; Cedazo-Minguez, A; Hassan, M; (2008) Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain. Pharmacological research, 58 (1). pp. 32-7. ISSN 1043-6618 DOI: https://doi.org/10.1016/j.phrs.2008.05.010 Full text not available from this repository.

Song, H; Vita, M; Sallam, H; Tehranchi, R; Nilsson, C; Sidén, A; Hassan, Z; (2007) Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro. Cancer chemotherapy and pharmacology, 60 (6). pp. 841-9. ISSN 0344-5704 DOI: https://doi.org/10.1007/s00280-007-0431-x Full text not available from this repository.

This list was generated on Fri Apr 17 06:37:30 2020 BST.